Skip to main content
. 2013 Apr 30;2013(4):CD003552. doi: 10.1002/14651858.CD003552.pub4

2.7. Analysis.

2.7

Comparison 2 Skin patches containing norelgestromin + EE versus COC norgestimate 250 µg + EE 35 µg, Outcome 7 Breakthrough bleeding or spotting (cycle 3): patch NGMN 150 µg + EE 20 µg versus OC.